Avidity Biosciences prices $600M stock offering

2 hours ago 1

Avidity Biosciences (NASDAQ:RNA) has priced an upsized offering of 15M shares at $40 each to raise gross proceeds of $600M.
In addition, the biopharmaceutical company has granted the underwriters a 30-day option to purchase up to an additional 2.25M shares. The offering